NeuroPace (NPCE) Stock Price Target Raised to $20 by H.C. Wainwright

H.C. Wainwright has increased its price target for NeuroPace (NPCE) to $20. This revision is based on the company's guidance, which suggests positive performance expectations in the near term. The bullish forecast may attract investor interest, potentially impacting NPCE's market performance. Analysts often adjust targets based on company guidance, making this development significant for current and prospective shareholders.